Patient Medical Records

Debate between Roger Godsiff and Barbara Keeley

Tuesday 4th March 2014 Westminster Hall

[Mr Godsiff]

I entirely agree with my hon. Friend and indeed, I will come to that point later. As I said, we have an opportunity in the next six months to try to get the scheme right. If the Government now address the many concerns raised about privacy, consent and the creeping commercialisation of our health service, they have the opportunity to create a scheme that offers enormous benefit to health care and research. However, if they fail to do that and continue to steamroll ahead, ignoring public concern, in six months’ time they will find themselves in precisely the same place as they are now, faced by massive public opposition to a scheme that has the potential to do so much good and to save lives.

[Barbara Keeley (Worsley and Eccles South) (Lab)]

I wonder whether my hon. Friend has noticed an issue that has emerged. NHS England uploaded a vast amount of hospital patient data—188 million records—to Google servers. That was done—we have already heard mention of the firm, Atos—by PA Consulting Group, which lost a Home Office contract a few years ago because of data loss. Does he agree that it appears that NHS England has now lost control of the IT side of the project, and that before we go forward, we need full disclosure of all the uses to date of patient data?

[Mr Godsiff]

My hon. Friend makes a very good point. I hope that the Under-Secretary of State for Health, the hon. Member for Central Suffolk and North Ipswich (Dr Poulter) has taken note of what she said and that the Department will be forthcoming in identifying exactly how much confidential NHS data have been released to private profit-making companies. He might also point out how much income the Government have received from that.

There are a huge number of problems with the existing scheme. I could mention the information leaflets that look more like junk mail and have no opt-out return slip on them, or the fact that data extraction was planned to start before the code of practice on who will be allowed to access the data was completed, or the lack of a clear figure on cost. However, perhaps the most damaging flaw in the whole plan has been the refusal to listen to or to address those concerns when they were raised by doctors and patients. We simply cannot and should not bring in a scheme that lacks the consent and approval of the vast majority of people whose confidential health data will be used.